Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Grant/Award of 10,000 GOSS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 26, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 7, 2024 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 9, 2023 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 35,000 | n/a |
| Jul 15, 2022 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 30,000 | n/a |
| Jun 30, 2022 | Magenta Therapeutics, Inc. (MGTA) | Grant/Award | 20,000 | n/a |
| Jun 10, 2021 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 23,500 | n/a |
| Jun 3, 2021 | Magenta Therapeutics, Inc. (MGTA) | Grant/Award | 18,188 | n/a |
| May 17, 2021 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 8,300 | n/a |